Nancy Miller-Rich

Director, Intercept Pharmaceuticals.

Companies

4D Molecular Therapeutics, Inc.Board member Dec 10, 2020 to now¹
Aldeyra Therapeutics, Inc.Board member Jan 15, 2020 to now²
Intercept PharmaceuticalsBoard member Apr 25, 2018 to Nov 13, 2023³
Kadmon Holdings, Inc.Board member Aug 13, 2020 to Nov 9, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aldeyra Therapeutics, Inc. ALDX922 shares⁵$702 at $0.76Apr 12, 2023
Intercept Pharmaceuticals ICPT0 shares⁶Nov 8, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 8, 2023Returned to company 8,111 shares at $19.00 of Intercept Pharmaceuticals⁶
Nov 8, 2023U 22,304 shares at $19.00 of Intercept Pharmaceuticals⁶
May 24, 2023Granted 8,111 shares of Intercept Pharmaceuticals⁷
Apr 12, 2023Bought 509 shares at $10.13 of Aldeyra Therapeutics, Inc.⁵
May 25, 2022Granted 7,737 shares of Intercept Pharmaceuticals⁸
May 3, 2021Bought 413 shares at $12.81 of Aldeyra Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAR4D Molecular Therapeutics, Inc., Board member
2
SEC EDGARAldeyra Therapeutics, Inc., Board member
3
SEC EDGARIntercept Pharmaceuticals, Board member
4
SEC EDGARKadmon Holdings, Inc., Board member
5
SEC EDGARAldeyra Therapeutics, Inc. shares after the filing of Apr 12, 2023
6
SEC EDGARIntercept Pharmaceuticals shares after the filing of Nov 8, 2023
7
SEC EDGARForm 4 filed May 25, 2023
8
SEC EDGARForm 4 filed May 27, 2022